Biocure Technology Inc.
CUREX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 92.18% | -100.75% | 92.40% | -593.06% | 61.78% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.72% | 100.07% | -95.31% | 4,065.13% | -20.91% |
| Change in Net Operating Assets | -74.82% | -47.36% | -26.51% | -59.11% | -79.22% |
| Cash from Operations | 65.22% | 291.75% | 99.73% | 127.10% | 93.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | 100.00% |
| Cash from Investing | -- | -- | -- | -100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -102.27% | -100.00% |
| Cash from Financing | -- | -- | -- | -137.82% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -100.00% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.22% | 3,000.00% | 97.49% | 89.41% | 74.44% |